| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 79.826 | 85.546 | 82.849 | 49.021 | 91.023 | 98.896 | 111.658 | 119.082 | 114.464 | 115.500 |
| Total Income - EUR | 79.831 | 85.552 | 82.856 | 49.023 | 91.025 | 98.897 | 111.660 | 119.083 | 114.465 | 115.501 |
| Total Expenses - EUR | 58.466 | 61.226 | 63.643 | 29.830 | 69.199 | 80.016 | 84.462 | 86.195 | 88.826 | 89.767 |
| Gross Profit/Loss - EUR | 21.364 | 24.326 | 19.213 | 19.192 | 21.825 | 18.882 | 27.198 | 32.889 | 25.639 | 25.734 |
| Net Profit/Loss - EUR | 17.946 | 22.615 | 18.385 | 18.702 | 20.914 | 17.892 | 26.081 | 31.697 | 24.493 | 22.268 |
| Employees | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dagma Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.391 | 2.639 | 1.718 | 2.004 | 2.441 | 2.070 | 606 | 439 | 438 | 0 |
| Current Assets | 53.957 | 59.334 | 23.179 | 41.389 | 53.193 | 70.387 | 26.794 | 32.583 | 37.700 | 26.204 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.765 | 2.701 | 3.647 | 3.905 | 775 | 761 | 744 | 23.790 | 6.611 | 740 |
| Cash | 51.192 | 56.633 | 19.531 | 37.484 | 52.417 | 69.626 | 26.050 | 8.794 | 31.089 | 25.464 |
| Shareholders Funds | 55.899 | 22.652 | 18.458 | 36.821 | 54.423 | 71.284 | 26.129 | 31.746 | 33.169 | 22.316 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.449 | 39.320 | 6.439 | 6.572 | 1.211 | 1.173 | 1.271 | 1.277 | 4.970 | 3.888 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dagma Med Srl